Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
Authors
Keywords
Atherosclerosis, Cardiovascular diseases, Hypertension, Nitric oxide, Reactive oxygen species, Uric acid, Xanthine oxidoreductase
Journal
Redox Biology
Volume 48, Issue -, Pages 102195
Publisher
Elsevier BV
Online
2021-11-24
DOI
10.1016/j.redox.2021.102195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update
- (2021) Arrigo F. G. Cicero et al. Medicina-Lithuania
- Uric Acid and Hypertension: Prognostic Role and Guide for Treatment
- (2021) Federica Piani et al. Journal of Clinical Medicine
- Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
- (2021) Tomoko Okuyama et al. Scientific Reports
- Plasma Xanthine Oxidoreductase Activity Is Associated with a High Risk of Cardiovascular Disease in a General Japanese Population
- (2021) Yuka Kotozaki et al. International Journal of Environmental Research and Public Health
- Xanthine oxidoreductase: One enzyme for multiple physiological tasks
- (2021) Massimo Bortolotti et al. Redox Biology
- Carotid Plaques From Symptomatic Patients Are Characterized by Local Increase in Xanthine Oxidase Expression
- (2021) Morsaleh Ganji et al. STROKE
- Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation
- (2020) Yoshitaka Kimura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Differential regulation of hypoxanthine and xanthine by obesity in a general population
- (2020) Masato Furuhashi et al. Journal of Diabetes Investigation
- Uric Acid and Hypertension: An Update With Recommendations
- (2020) Laura G Sanchez-Lozada et al. AMERICAN JOURNAL OF HYPERTENSION
- l-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells
- (2020) Marcello Rattazzi et al. ATHEROSCLEROSIS
- Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes
- (2020) Mineko Terao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study
- (2020) Masanari Kuwabara et al. Journal of Clinical Medicine
- Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
- (2020) Ken Watanabe et al. ESC Heart Failure
- Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
- (2020) Claudio Borghi et al. European Journal of Internal Medicine
- Xanthine oxidase-lactoperoxidase system and innate immunity: Biochemical actions and physiological roles
- (2020) Saad S. Al-Shehri et al. Redox Biology
- The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans
- (2020) Stefano Masi et al. Journal of Clinical Medicine
- Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors
- (2020) Milton Packer JOURNAL OF CARDIAC FAILURE
- Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence
- (2020) Muthukumaran Jayachandran et al. MEDICINAL RESEARCH REVIEWS
- Uric Acid and Vascular Damage in Essential Hypertension: Role of Insulin Resistance
- (2020) Velia Cassano et al. Nutrients
- Pro-Aging Effects of Xanthine Oxidoreductase Products
- (2020) Maria Giulia Battelli et al. Antioxidants
- Gout Is Prevalent but Under-Registered Among Patients With Cardiovascular Events: A Field Study
- (2020) Irene Calabuig et al. Frontiers in Medicine
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
- (2020) Wei Yu et al. Frontiers in Pharmacology
- Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure
- (2020) Andreas Daiber et al. FREE RADICAL BIOLOGY AND MEDICINE
- Potential dangers of serum urate-lowering therapy
- (2019) Maria Vanessa Perez-Gomez et al. AMERICAN JOURNAL OF MEDICINE
- Uric Acid-Induced Enhancements of Kv1.5 Protein Expression and Channel Activity via the Akt-HSF1-Hsp70 Pathway in HL-1 Atrial Myocytes
- (2019) Fikri Taufiq et al. CIRCULATION JOURNAL
- Hepatocyte-Specific Ablation or Whole-Body Inhibition of Xanthine Oxidoreductase in Mice Corrects Obesity-Induced Systemic Hyperuricemia Without Improving Metabolic Abnormalities
- (2019) Daniel B. Harmon et al. DIABETES
- Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects
- (2019) Francesca Cortese et al. VASCULAR PHARMACOLOGY
- Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
- (2019) Sebastian Steven et al. Oxidative Medicine and Cellular Longevity
- Serum uric acid and fatal myocardial infarction
- (2019) Edoardo Casiglia et al. JOURNAL OF HYPERTENSION
- Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
- (2018) Richard J. Johnson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The role of xanthine oxidoreductase and uric acid in metabolic syndrome
- (2018) Maria Giulia Battelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Uric Acid Induces Cardiomyocyte Apoptosis via Activation of Calpain-1 and Endoplasmic Reticulum Stress
- (2018) Meiling Yan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Uric acid and cardiovascular disease
- (2018) Gjin Ndrepepa CLINICA CHIMICA ACTA
- Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan
- (2018) Masanari Kuwabara et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study
- (2018) S. Goya Wannamethee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study
- (2018) Sumito Sunagawa et al. Journal of Diabetes Investigation
- Hyperuricemia and endothelial function: From molecular background to clinical perspectives
- (2018) Tatsuya Maruhashi et al. ATHEROSCLEROSIS
- Treating oxidative stress in heart failure: past, present and future
- (2018) Atze van der Pol et al. EUROPEAN JOURNAL OF HEART FAILURE
- Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
- (2018) Maria Giulia Battelli et al. Redox Biology
- Uric acid enhances longevity and endurance and protects the brain against ischemia
- (2018) Roy G. Cutler et al. NEUROBIOLOGY OF AGING
- Physiological role of reactive oxygen species as promoters of natural defenses
- (2017) Jérôme Roy et al. FASEB JOURNAL
- Unexpected effect of urate on hydrogen peroxide-induced oxidative damage in embryonic chicken cardiac cells
- (2017) Xiaolong Sun et al. FREE RADICAL RESEARCH
- Uric Acid Is a Strong Risk Marker for Developing Hypertension From PrehypertensionNovelty and Significance
- (2017) Masanari Kuwabara et al. HYPERTENSION
- Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
- (2017) Yoichiro Otaki et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?
- (2017) Anila Duni et al. Oxidative Medicine and Cellular Longevity
- Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
- (2017) Yuki Fujimura et al. PLoS One
- Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme
- (2016) Maria Giulia Battelli et al. CURRENT MEDICINAL CHEMISTRY
- Enhanced XOR activity in eNOS-deficient mice
- (2016) Maria Peleli et al. FREE RADICAL BIOLOGY AND MEDICINE
- Uric acid and xanthine oxidase in heart failure — Emerging data and therapeutic implications
- (2016) Wolfram Doehner et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis
- (2016) Tianqiang Qin et al. Journal of Clinical Hypertension
- Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis
- (2016) Akifumi Kushiyama et al. MEDIATORS OF INFLAMMATION
- Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects
- (2016) Maria Giulia Battelli et al. Oxidative Medicine and Cellular Longevity
- Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study
- (2016) Kasper Søltoft Larsen et al. PLoS One
- Weight Loss, Xanthine Oxidase, and Serum Urate Levels: A Prospective Longitudinal Study of Obese Patients
- (2016) Pascal Richette et al. ARTHRITIS CARE & RESEARCH
- Xanthine Oxidase and Cardiovascular Risk in Obese Children
- (2016) Harrison K. Tam et al. Childhood Obesity
- The C-terminal peptide plays a role in the formation of an intermediate form during the transition between xanthine dehydrogenase and xanthine oxidase
- (2015) Tomoko Nishino et al. FEBS Journal
- Serum uric acid and the risk of cardiovascular and renal disease
- (2015) Claudio Borghi et al. JOURNAL OF HYPERTENSION
- The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)
- (2015) Hawa N. Siti et al. VASCULAR PHARMACOLOGY
- Relationship between Hyperuricemia and Lipid Profiles in US Adults
- (2015) Tao-Chun Peng et al. Biomed Research International
- Xanthine oxidoreductase in cancer: more than a differentiation marker
- (2015) Maria Giulia Battelli et al. Cancer Medicine
- Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress
- (2014) Maria Giulia Battelli et al. ATHEROSCLEROSIS
- Pathophysiology of circulating xanthine oxidoreductase: New emerging roles for a multi-tasking enzyme
- (2014) Maria Giulia Battelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Serum uric acid and cardiovascular risk: State of the art and perspectives
- (2014) Goël Fenech et al. JOINT BONE SPINE
- The pathophysiology of hypertension in patients with obesity
- (2014) Vincent G. DeMarco et al. Nature Reviews Endocrinology
- Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease
- (2014) Milojkovic Boban et al. RENAL FAILURE
- Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
- (2014) Johji Nomura et al. Scientific Reports
- Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation
- (2013) Nadiezhda Cantu-Medellin et al. Redox Biology
- Identification of Proteins Binding to E-Box/Ku86 Sites and Function of the Tumor Suppressor SAFB1 in Transcriptional Regulation of the Human Xanthine Oxidoreductase Gene
- (2008) Junji Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started